This $2,729,018 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and evaluation of a mobile health intervention for individuals with co-occurring opioid use disorder (OUD) and post-traumatic stress disorder (PTSD) during the critical community re-entry period following residential OUD treatment. The key products to be delivered through this grant include a rigorously developed...
This federal Project Grant award, with ID R61DA061296, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $1,948,634 award will fund the development and evaluation of a mobile health (mHealth) intervention called "OD-CHESS" to reduce overdose risk among people who engage in polysubstance use. The project aims to adapt an existing substance use disorder intervention called A-CHESS into the OD-CHESS...
This $280,207 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to develop a novel mobile health intervention called the Adolescent CLEAR30 (A-CLEAR30) to reduce cannabis use among youth aged 13-17. The project will leverage the framework of the existing CLEAR30 mobile program and tailor it to the specific needs of adolescent users, including personalized feedback, daily communications, guided meditations,...
This Project Grant award, with a total funding amount of $958,629, was awarded by the National Institute on Drug Abuse (NIDA) under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The funding will support the real-world adoption of an innovative digital health therapeutic called KIOS, which uses nonlinear control theory to track multiple symptoms (e.g., craving, mood, pain) and deliver personalized, evidence-based intervention strategies to patients with opioid use disorder...
This federal Project Grant award of $2,164,152 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to test the effectiveness and implementation of a meditation mobile application among youth on probation in Cook County, Illinois. The key products and services to be delivered include: Conducting a hybrid type 2 effectiveness-implementation randomized controlled trial with 300 youth on probation to evaluate if the meditation...
The National Institute on Drug Abuse (NIDA) awarded a $800,000 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Tenvos Inc., a minority-owned and woman-owned technology company. The grant will support the development of a software-based medical device (SAMD) integrated into a smartphone application that can detect opioid use through voice analysis. The proposed solution aims to enable patients in outpatient opioid use disorder (OUD) treatment to remotely test for...
This federal Project Grant award of $591,848 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) supports the development of a smart speaker-based application to improve housing stability and provide support for individuals with substance use disorders (SUD) living in supportive housing communities. The key products or services to be delivered through this award include: Collaborating with community partners to understand implementation determinants...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to address racial disparities in opioid overdose deaths. The $451,962 grant, awarded on July 1, 2024, supports the development and evaluation of a multimodal intervention consisting of an AI-driven texting tool and peer recovery coach (PRC) telephone-based services coordination for Black and Latinx people who use opioids. The key products and services to...
The National Institute on Drug Abuse (NIDA) awarded a $390,000 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Regents of the University of Michigan. The grant, titled "Cultivating Recovery: A Pilot Study of Digital Contingency Management for Co-Occurring Opioid and Alcohol Use Disorder," will fund a mixed-methods randomized pilot trial to test the feasibility and acceptability of a digital contingency management intervention for Medicaid...
The National Institute on Drug Abuse (NIDA) awarded Evidation Health, Inc. a $304,023 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop RESHAPE, a digital platform addressing health-related social needs for individuals with substance use disorders (SUD). The goal of the project is to create a comprehensive digital experience that supports SUD recovery by providing personalized education, insights, and support. The RESHAPE platform will leverage...
This $857,121 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) aims to develop and test a prototype mobile health (mHealth) application called R-Assist. The R-Assist app is designed to support individuals with co-occurring opioid use and mental health disorders as they transition from jail to the community. The key features of the R-Assist app include daily symptom and medication monitoring, a self-help curriculum, a resource finder for social determinants of health, and an engagement dashboard. The project is a partnership between the University of Massachusetts and the small business Meaningful Measurement, Inc. The award will fund the development of the R-Assist prototype and a small open pilot study with 20 clients leaving jail, in preparation for a larger Phase II trial. This effort aligns with NIDA's goals of developing low-cost technologies to increase access to treatment for underserved populations.